1/7/2024 0 Comments Fidelia osinubiQuality of care measures (effective and timely treatment) were determined using the conceptual framework developed by the Institutes of Medicine (IOM) to characterize healthcare quality as effective and timely. Using Practice Guidelines to Define Quality of Care Measures The second objective was to determine if differences in colon cancer treatment quality explained differences in mortality rates. The authors undertook this study to assess Black-White differences in the quality of stage-specific colon cancer treatment in a patient population comparable in size and demographic characteristics, thereby adjusting for sociodemographic factors. It is evident that further Black-White comparison research on the quality of colon cancer treatment is needed. 16, 17, 19, 20 - 27 The majority of studies did not apply standardized quality of care measures and did not examine treatment delay. Although racial disparities in treatment were consistently indicated in many of these studies, the ratio of Blacks to Whites was generally low and sociodemographic factors were dissimilar. 16, 17, 18, 19, 20 - 26 Blacks generally did not receive surgery, chemotherapy, radiation therapy, or follow-up surveillance at the same rate as Whites even when their disease stage was less advanced. Most studies that examined the quality of stage-specific colorectal cancer treatment found notable Black-White differences. Fecal occult blood testing rates (FOBT) were 19.2% and 19.4%, respectively and colonoscopy/sigmoidoscopy rates were 44.3% and 47.0%, respectively. 13 - 15 Recent reports from the American Cancer Society suggests that gaps between Blacks and Whites in colorectal cancer screening are relatively small. Racial disparities in colorectal cancer mortality may be more aptly explained by variances in treatment.Ī number of empirical studies have identified statistically significant differences between Blacks and Whites in colorectal cancer screening practices, 9, 10, 11, 12 while other studies have found no significant differences. 8 These statistics suggest that tumor biology alone may not fully explain the excess mortality seen among Black patients. 8 Similarly, colorectal cancer mortality rates among Whites progressively decreased since the 1950s in women and the 1980s in men, while increasing before leveling off during the mid 1980s and early 1990s in Black women and men, respectively. Incidence rates increased sharply in Black men between 19 before leveling off and remained level in Black women, while incidence rates steadily decreased in White men and women. As treatment options for colorectal cancer advanced, disparities between Blacks and Whites grew substantially. 3 - 7 However, prior to the mid 1970s, Blacks did not experience disparities in colorectal cancer incidence or mortality. Some studies suggest racial disparities in colorectal cancer incidence and mortality may be attributed to tumor biology. 2 Over the past 25 years, the Black-White disparity in mortality has increased annually in males and females. Colorectal cancer incidence rates are 1.2 times higher in Black males than White males and 1.3 times higher in Black females than White females mortality rates are 1.4 times higher in both Black males and females than their White counterparts. 1 Blacks are burdened with higher mortality rates in all cancer sites combined including colorectal cancer. In 2008, an estimated 148,810 new cases of colorectal cancer were expected to be diagnosed, and 8.8% of all cancer deaths (49,960) were expected to occur due to colorectal cancer. Published on January 18, 2005.Colorectal cancer is the third most common cancer. The business address is 3441 Dickerson Pike, Nashville, TN 37207-2539. The organization name is SKYLINE NEUROSCIENCE ASSOCIATES LLC. Sonya Fidelia Brooks is a neurology enrolled with Centers for Medicare & Medicaid Services (CMS).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |